You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Drug misuse

Naltrexone for the management of opioid dependence

  • Technology appraisal guidance
  • Reference number: TA115
  • Published:  24 January 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 Information about naltrexone
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Appraisal Committee members and NICE project team
  • 7 Sources of evidence considered by the Committee
  • Update information

Update information

March 2014: Implementation section updated to clarify that naltrexone is recommended as an option for treating opioid dependence. Additional minor maintenance update also carried out.

ISBN: 978-1-4731-5679-1


Previous page 7 Sources of evidence considered by the Committee